{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:39:08Z","timestamp":1776911948035,"version":"3.51.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tampere University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04223-0","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:19:03Z","timestamp":1773667143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adherence to asthma medication and asthma control in Finland"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0596-2137","authenticated-orcid":false,"given":"Petri","family":"Salmela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Pakkasela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Juntunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iida","family":"V\u00e4h\u00e4talo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Karjalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"10258","key":"4223_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Global burden","year":"2020","unstructured":"Global burden. of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"key":"4223_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.rmed.2019.06.003","volume":"154","author":"J Honkam\u00e4ki","year":"2019","unstructured":"Honkam\u00e4ki J, Hisinger-M\u00f6lk\u00e4nen H, Ilmarinen P, Piiril\u00e4 P, Tuomisto LE, Anders\u00e9n H, et al. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood. Respir Med. 2019;154:56\u201362.","journal-title":"Respir Med"},{"key":"4223_CR3","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. www.ginasthma.org. 2022;(Generic). Available from: www.ginasthma.org."},{"issue":"8","key":"4223_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/thx.2005.055699","volume":"61","author":"T Haahtela","year":"2006","unstructured":"Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006;61(8):663\u201370.","journal-title":"Thorax"},{"key":"4223_CR5","unstructured":"Working group appointed by the Finnish Medical Society Duodecim, the Finnish Respiratory. Society, the Finnish Paediatric Society, the Finnish Society of Clinical Physiology. Asthma. Current Care Guidelines. . The Finnish Medical Society Duodecim; 2022. Available from: www.kaypahoito.fi."},{"key":"4223_CR6","unstructured":"Working group appointed by the Finnish Medical Society Duodecim. the Finnish Respiratory Society, the Finnish Paediatric Society, the Finnish Society of Clinical Physiology. Asthma. Curr Care Guidelines. 2013 [cited 2021 Nov 22]. Available from: www.kaypahoito.fi."},{"key":"4223_CR7","doi-asserted-by":"publisher","first-page":"106244","DOI":"10.1016\/j.rmed.2020.106244","volume":"176","author":"M Bassam","year":"2021","unstructured":"Bassam M, Behbehani N, Farouk H, Alsayed M, Montestruc F, Al-Jahdali H, et al. Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study. Respir Med. 2021;176:106244.","journal-title":"Respir Med"},{"issue":"3","key":"4223_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4187\/respcare.03200","volume":"60","author":"CB B\u00e5rnes","year":"2015","unstructured":"B\u00e5rnes CB, Ulrik CS. Asthma and Adherence to Inhaled Corticosteroids: Current Status and Future Perspectives. Respir Care. 2015;60(3):455\u201368.","journal-title":"Respir Care"},{"key":"4223_CR9","doi-asserted-by":"publisher","unstructured":"Brennan V, Mulvey C, Costello RW. The clinical impact of adherence to therapy in airways disease. Breathe. 2021;17(2):210039. https:\/\/doi.org\/10.1183\/20734735.0039-2021.","DOI":"10.1183\/20734735.0039-2021"},{"issue":"2","key":"4223_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1183\/09031936.00075614","volume":"45","author":"M Engelkes","year":"2015","unstructured":"Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396\u2013407.","journal-title":"Eur Respir J"},{"issue":"1","key":"4223_CR11","doi-asserted-by":"publisher","first-page":"00324","DOI":"10.1183\/23120541.00324-2019","volume":"6","author":"I V\u00e4h\u00e4talo","year":"2020","unstructured":"V\u00e4h\u00e4talo I, Ilmarinen P, Tuomisto LE, Tommola M, Niemel\u00e4 O, Lehtim\u00e4ki L, et al. 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Res. 2020;6(1):00324\u20132019.","journal-title":"ERJ Open Res"},{"issue":"3","key":"4223_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1183\/09031936.00165106","volume":"30","author":"TR Bai","year":"2007","unstructured":"Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452\u20136.","journal-title":"Eur Respir J"},{"issue":"5","key":"4223_CR13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jaci.2012.01.039","volume":"129","author":"JI Ivanova","year":"2012","unstructured":"Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129(5):1229\u201335.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"4223_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40258-019-00469-4","volume":"17","author":"K Vellopoulou","year":"2019","unstructured":"Vellopoulou K, Bakakos P, Loukides S, Maniadakis N, Kourlaba G. The Economic Burden of Asthma in Greece: A Cross-Sectional Study. Appl Health Econ Health Policy. 2019;17(5):629\u201340.","journal-title":"Appl Health Econ Health Policy"},{"key":"4223_CR15","doi-asserted-by":"publisher","first-page":"105919","DOI":"10.1016\/j.rmed.2020.105919","volume":"165","author":"M Engelkes","year":"2020","unstructured":"Engelkes M, de Ridder MA, Svensson E, Berencsi K, Prieto-Alhambra D, Lapi F, et al. Multinational cohort study of mortality in patients with asthma and severe asthma. Respir Med. 2020;165:105919.","journal-title":"Respir Med"},{"issue":"5","key":"4223_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.anai.2021.08.014","volume":"127","author":"DJ Jackson","year":"2021","unstructured":"Jackson DJ, Bacharier LB. Inhaled corticosteroids for the prevention of asthma exacerbations. Ann Allergy Asthma Immunol. 2021;127(5):524\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"4223_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jama.292.3.367","volume":"292","author":"DD Sin","year":"2004","unstructured":"Sin DD, Man J, Sharpe H, Gan WQ, Man SFP. Pharmacological Management to Reduce Exacerbations in Adults With AsthmaA Systematic Review and Meta-analysis. JAMA. 2004;292(3):367\u201376.","journal-title":"JAMA"},{"issue":"9","key":"4223_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.200902-0166OC","volume":"180","author":"J Gamble","year":"2009","unstructured":"Gamble J, Stevenson M, McClean E, Heaney LG. The Prevalence of Nonadherence in Difficult Asthma. Am J Respir Crit Care Med. 2009;180(9):817\u201322.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4223_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1081-1206(10)60808-3","volume":"97","author":"L Stern","year":"2006","unstructured":"Stern L, Berman J, Lumry W, Katz L, Wang L, Rosenblatt L, et al. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Ann Allergy Asthma Immunol. 2006;97(3):402\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"4223_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2011.09.011","volume":"128","author":"LK Williams","year":"2011","unstructured":"Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid non-adherence. J Allergy Clin Immunol. 2011;128(6):1185\u2013e11912.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"4223_CR21","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.jaip.2018.03.008","volume":"6","author":"A Papi","year":"2018","unstructured":"Papi A, Ryan D, Soriano JB, Chrystyn H, Bjermer L, Rodr\u00edguez-Roisin R, et al. Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2018;6(6):1989\u2013e19983.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"4223_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4104\/pcrj.2009.00037","volume":"18","author":"J Clatworthy","year":"2009","unstructured":"Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J J Gen Pract Airw Group. 2009;18(4):300\u20135.","journal-title":"Prim Care Respir J J Gen Pract Airw Group"},{"issue":"1","key":"4223_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40413-015-0075-y","volume":"8","author":"D Price","year":"2015","unstructured":"Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8(1):26.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"4223_CR24","doi-asserted-by":"publisher","first-page":"00715","DOI":"10.1183\/23120541.00715-2020","volume":"7","author":"I V\u00e4h\u00e4talo","year":"2021","unstructured":"V\u00e4h\u00e4talo I, Kankaanranta H, Tuomisto LE, Niemel\u00e4 O, Lehtim\u00e4ki L, Ilmarinen P. Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma. ERJ Open Res. 2021;7(1):00715\u20132020.","journal-title":"ERJ Open Res"},{"issue":"1","key":"4223_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12890-024-02870-9","volume":"24","author":"P Juntunen","year":"2024","unstructured":"Juntunen P, Salmela P, Pakkasela J, Karjalainen J, Lehtim\u00e4ki L. Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland. BMC Pulm Med. 2024;24(1):64.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"4223_CR26","doi-asserted-by":"publisher","first-page":"2149918","DOI":"10.1080\/20018525.2022.2149918","volume":"10","author":"J Pakkasela","year":"2023","unstructured":"Pakkasela J, Salmela P, Juntunen P, Karjalainen J, Lehtim\u00e4ki L. Adherence to treatment guidelines and good asthma control in Finland. Eur Clin Respir J. 2023;10(1):2149918.","journal-title":"Eur Clin Respir J"},{"issue":"3","key":"4223_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","volume":"117","author":"M Schatz","year":"2006","unstructured":"Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549\u201356.","journal-title":"J Allergy Clin Immunol"},{"key":"4223_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/CLEP.S333534","volume":"13","author":"M Asamoah-Boaheng","year":"2021","unstructured":"Asamoah-Boaheng M, Osei Bonsu K, Farrell J, Oyet A, Midodzi WK. Measuring Medication Adherence in a Population-Based Asthma Administrative Pharmacy Database: A Systematic Review and Meta-Analysis. Clin Epidemiol. 2021;13:981\u20131010.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"4223_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/pds.3935","volume":"25","author":"MJ Bijlsma","year":"2016","unstructured":"Bijlsma MJ, Janssen F, Hak E. Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method. Pharmacoepidemiol Drug Saf. 2016;25(3):325\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"4223_CR30","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","volume":"199","author":"R Beasley","year":"2019","unstructured":"Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019;199(12):1471\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4223_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.rmed.2018.02.025","volume":"137","author":"I V\u00e4h\u00e4talo","year":"2018","unstructured":"V\u00e4h\u00e4talo I, Ilmarinen P, Tuomisto LE, Niemel\u00e4 O, Kankaanranta H. Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study. Respir Med. 2018;137:70\u20136.","journal-title":"Respir Med"},{"issue":"3","key":"4223_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pcrj.2006.02.009","volume":"15","author":"M Thomas","year":"2006","unstructured":"Thomas M, Leather D, Price D. High-dose inhaled corticosteroids and add-on therapy use in adults with asthma in the UK in 2003: an observational study. Prim Care Respir J J Gen Pract Airw Group. 2006;15(3):166\u201372.","journal-title":"Prim Care Respir J J Gen Pract Airw Group"},{"issue":"4","key":"4223_CR33","first-page":"183","volume":"8","author":"S Serhal","year":"2020","unstructured":"Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Wilson F, Armour C. Medication Adherence in a Community Population with Uncontrolled Asthma. Pharm J Pharm Educ Pract. 2020;8(4):183.","journal-title":"Pharm J Pharm Educ Pract"},{"issue":"2","key":"4223_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaip.2022.11.030","volume":"11","author":"R Beasley","year":"2023","unstructured":"Beasley R, Kankaanranta H. Inhaled Corticosteroids in Asthma: When Less Is More. J Allergy Clin Immunol Pract. 2023;11(2):544\u20135.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"4223_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jaip.2022.10.040","volume":"11","author":"ID Pavord","year":"2023","unstructured":"Pavord ID, Tran TN, Jones RC, Nuevo J, Berge M, van den, Brusselle GG, et al. Effect of Stepping Up to High-Dose Inhaled Corticosteroids in Patients With Asthma: UK Database Study. J Allergy Clin Immunol Pract. 2023;11(2):532\u201343.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"4223_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaip.2023.09.034","volume":"12","author":"H Kankaanranta","year":"2024","unstructured":"Kankaanranta H, Viinanen A, Ilmarinen P, Hisinger-M\u00f6lk\u00e4nen H, Meht\u00e4l\u00e4 J, Ylisaukko-oja T, et al. Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA). J Allergy Clin Immunol Pract. 2024;12(1):135\u2013e1459.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4223_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41533-020-0166-2","volume":"30","author":"J Takala","year":"2020","unstructured":"Takala J, Ilmarinen P, Tuomisto LE, V\u00e4h\u00e4talo I, Niemel\u00e4 O, Kankaanranta H. Planned primary health care asthma contacts during 12-year follow-up after Finnish National Asthma Programme: focus on spirometry. NPJ Prim Care Respir Med. 2020;30:8.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"1","key":"4223_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12890-022-01850-1","volume":"22","author":"J Takala","year":"2022","unstructured":"Takala J, V\u00e4h\u00e4talo I, Tuomisto LE, Niemel\u00e4 O, Ilmarinen P, Kankaanranta H. Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up in patients with adult-onset asthma. BMC Pulm Med. 2022;22(1):63.","journal-title":"BMC Pulm Med"},{"issue":"17","key":"4223_CR39","doi-asserted-by":"publisher","first-page":"E784","DOI":"10.1503\/cmaj.122010","volume":"185","author":"M Kivim\u00e4ki","year":"2013","unstructured":"Kivim\u00e4ki M, Batty GD, Hamer M, Nabi H, Korhonen M, Huupponen R, et al. Influence of retirement on nonadherence to medication for hypertension and diabetes. CMAJ Can Med Assoc J. 2013;185(17):E784\u201390.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"6","key":"4223_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/ane.13301","volume":"142","author":"S Lahdenper\u00e4","year":"2020","unstructured":"Lahdenper\u00e4 S, Soilu-H\u00e4nninen M, Kuusisto HM, Atula S, Junnila J, Berglund A. Medication adherence\/persistence among patients with active multiple sclerosis in Finland. Acta Neurol Scand. 2020;142(6):605\u201312.","journal-title":"Acta Neurol Scand"},{"key":"4223_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.genhosppsych.2021.12.012","volume":"74","author":"K Teppo","year":"2022","unstructured":"Teppo K, Jaakkola J, Airaksinen KEJ, Biancari F, Halminen O, Putaala J, et al. Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study. Gen Hosp Psychiatry. 2022;74:88\u201393.","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"4223_CR42","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.jaip.2023.03.053","volume":"11","author":"H De Keyser","year":"2023","unstructured":"De Keyser H, Vuong V, Kaye L, Anderson WC, Szefler S, Stempel DA. Is once versus twice daily dosing better for adherence in asthma and COPD? J Allergy Clin Immunol Pract. 2023;11(7):2087\u2013e20933.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4223_CR43","doi-asserted-by":"publisher","unstructured":"Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, et al. Dosing Frequency and Medication Adherence in Chronic Disease. J Manag Care Pharm JMCP. 2012;18(7):527\u2013539. https:\/\/doi.org\/10.18553\/jmcp.2012.18.7.527.","DOI":"10.18553\/jmcp.2012.18.7.527"},{"issue":"4","key":"4223_CR44","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1183\/09031936.00172114","volume":"45","author":"AL Dima","year":"2015","unstructured":"Dima AL, Hernandez G, Cunillera O, Ferrer M, de Bruin M, ASTRO-LAB group. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J. 2015;45(4):994\u20131018.","journal-title":"Eur Respir J"},{"key":"4223_CR45","doi-asserted-by":"publisher","unstructured":"Monteiro C, Maricoto T, Prazeres F, Sim\u00f5es PA, Sim\u00f5es JA. Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respir Med. 2022;191. https:\/\/doi.org\/10.1016\/j.rmed.2021.106724.","DOI":"10.1016\/j.rmed.2021.106724"},{"issue":"1","key":"4223_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-022-00310-x","volume":"32","author":"M Vervloet","year":"2022","unstructured":"Vervloet M, van Dijk L, Weesie YM, Kocks JWH, Dima AL, Korevaar JC. Understanding relationships between asthma medication use and outcomes in a SABINA primary care database study. Npj Prim Care Respir Med. 2022;32(1):1\u201310.","journal-title":"Npj Prim Care Respir Med"},{"issue":"6","key":"4223_CR47","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jaci.2004.09.028","volume":"114","author":"LK Williams","year":"2004","unstructured":"Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"4223_CR48","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1513\/AnnalsATS.201603-222OC","volume":"13","author":"I Sulaiman","year":"2016","unstructured":"Sulaiman I, Seheult J, MacHale E, Boland F, O\u2019Dwyer SM, Rapcan V, et al. A Method to Calculate Adherence to Inhaled Therapy that Reflects the Changes in Clinical Features of Asthma. Ann Am Thorac Soc. 2016;13(11):1894\u2013903.","journal-title":"Ann Am Thorac Soc"},{"key":"4223_CR49","doi-asserted-by":"publisher","unstructured":"Gyawali B, Georas SN, Khurana S. Biologics in severe asthma: a state-of-the-art review. Eur Respir Rev. 2025;34(175):240088. https:\/\/doi.org\/10.1183\/16000617.0088-2024.","DOI":"10.1183\/16000617.0088-2024"},{"issue":"1","key":"4223_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jaip.2022.10.014","volume":"11","author":"PJ Cvietusa","year":"2023","unstructured":"Cvietusa PJ, Goodrich GK, Shoup JA, King DK, Bender BG. Effect of an Asthma Exacerbation on Medication Adherence. J Allergy Clin Immunol Pract. 2023;11(1):248\u201354.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4223_CR51","doi-asserted-by":"publisher","unstructured":"Khezrian M, Kerkhof M, Le TT, Harrison T, Wu TD, Cook B et al. Adherence to inhaled corticosteroid medications after an asthma exacerbation and the risk of subsequent exacerbations. Ann Allergy Asthma Immunol. 2025 Aug 13 https:\/\/doi.org\/10.1016\/j.anai.2025.08.007.","DOI":"10.1016\/j.anai.2025.08.007"},{"key":"4223_CR52","doi-asserted-by":"publisher","unstructured":"Holmes J, Heaney LG. Measuring adherence to therapy in airways disease. Breathe . 2021;17(2). https:\/\/doi.org\/10.1183\/20734735.0037-2021.","DOI":"10.1183\/20734735.0037-2021"},{"issue":"1","key":"4223_CR53","first-page":"A13","volume":"2","author":"BCK Choi","year":"2004","unstructured":"Choi BCK, Pak AWP. A Catalog of Biases in Questionnaires. Prev Chronic Dis. 2004;2(1):A13.","journal-title":"Prev Chronic Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04223-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04223-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:02:34Z","timestamp":1776909754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04223-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04223-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Helsinki Declaration and informed consent to participate was obtained from all of the participants in the study. The study protocol was approved by the Ethics Committee of Tampere University Hospital (approval number R15186).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PS reports fees for lectures and advisory board meetings from Astra Zeneca, Chiesi, GSK, Boehringer Ingelheim and Sanofi. JP reports fees for lectures from GSK. PJ and IV has nothing to disclose. HK reports fees for lectures and advisory board meetings from AstraZeneca, Boehringer-Ingelheim, Covis Pharma, GSK, Orion Pharma and Sanofi. JK report fees for lectures and advisory board meetings from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Sanofi and Orion Pharma. LL report fees for lectures and advisory board meetings from ALK, AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Chiesi, GSK, Menarini, Novartis, Sanofi and Orion Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}